These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23368866)

  • 1. Connective tissue growth factor immunohistochemical expression is associated with gallbladder cancer progression.
    Garcia P; Leal P; Alvarez H; Brebi P; Ili C; Tapia O; Roa JC
    Arch Pathol Lab Med; 2013 Feb; 137(2):245-50. PubMed ID: 23368866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial analysis of gene expression identifies connective tissue growth factor expression as a prognostic biomarker in gallbladder cancer.
    Alvarez H; Corvalan A; Roa JC; Argani P; Murillo F; Edwards J; Beaty R; Feldmann G; Hong SM; Mullendore M; Roa I; Ibañez L; Pimentel F; Diaz A; Riggins GJ; Maitra A
    Clin Cancer Res; 2008 May; 14(9):2631-8. PubMed ID: 18451226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical expression of vascular endothelial growth factor A in advanced gallbladder carcinoma.
    Letelier P; Garcia P; Leal P; Ili C; Buchegger K; Riquelme I; Sandoval A; Tapia O; Roa JC
    Appl Immunohistochem Mol Morphol; 2014 Aug; 22(7):530-6. PubMed ID: 24185122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Female Sex Hormone Receptors, Connective Tissue Growth Factor and HER2 in Gallbladder Cancer.
    Hryciuk B; Pęksa R; Bieńkowski M; Szymanowski B; Radecka B; Winnik K; Żok J; Cichowska N; Iliszko M; Duchnowska R
    Sci Rep; 2020 Feb; 10(1):1871. PubMed ID: 32024900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of phospho-mTOR is associated with poor prognosis in patients with gallbladder adenocarcinoma.
    Leal P; García P; Sandoval A; Letelier P; Brebi P; Ili C; Álvarez H; Tapia O; Roa JC
    Arch Pathol Lab Med; 2013 Apr; 137(4):552-7. PubMed ID: 23544944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological significance of DNA fragmentation factor 45 and thyroid transcription factor 1 expression in benign and malignant lesions of the gallbladder.
    Yuan Y; Yang ZL; Zou Q; Cao LF; Tan XG; Jiang S; Miao XY
    Pol J Pathol; 2013 Apr; 64(1):44-51. PubMed ID: 23625600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant activation of Sonic hedgehog signaling in chronic cholecystitis and gallbladder carcinoma.
    Xie F; Xu X; Xu A; Liu C; Liang F; Xue M; Bai L
    Hum Pathol; 2014 Mar; 45(3):513-21. PubMed ID: 24440094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ERK/MAPK pathway is overexpressed and activated in gallbladder cancer.
    Buchegger K; Silva R; López J; Ili C; Araya JC; Leal P; Brebi P; Riquelme I; Roa JC
    Pathol Res Pract; 2017 May; 213(5):476-482. PubMed ID: 28285962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic significance of minichromosome maintenance protein 2 and Tat-interacting protein 30 expression in benign and malignant lesions of the gallbladder.
    Liu DC; Yang ZL
    Hum Pathol; 2011 Nov; 42(11):1676-83. PubMed ID: 21543106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of S1P1 and ERp29 expression to progression, metastasis, and poor prognosis of gallbladder adenocarcinoma.
    Yuan LW; Liu DC; Yang ZL
    Hepatobiliary Pancreat Dis Int; 2013 Apr; 12(2):189-95. PubMed ID: 23558074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of connective tissue growth factor (CTGF/CCN2) in gallbladder cancer cells leads to decreased growth in vitro.
    Garcia P; Leal P; Ili C; Brebi P; Alvarez H; Roa JC
    Int J Exp Pathol; 2013 Jun; 94(3):195-202. PubMed ID: 23593935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress and deregulations in base excision repair pathway as contributors to gallbladder anomalies and carcinoma - a study involving North-East Indian population.
    Singh N; Kazim SN; Sultana R; Tiwari D; Borkotoky R; Kakati S; Nath Das N; Kumar Saikia A; Bose S
    Free Radic Res; 2019 May; 53(5):473-485. PubMed ID: 31117842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical study of PUMA, c-Myb and p53 expression in the benign and malignant lesions of gallbladder and their clinicopathological significances.
    Shu GS; Lv F; Yang ZL; Miao XY
    Int J Clin Oncol; 2013 Aug; 18(4):641-50. PubMed ID: 22714709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of PEG10 and TSG101 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma.
    Liu DC; Yang ZL; Jiang S
    Pathol Oncol Res; 2011 Dec; 17(4):859-66. PubMed ID: 21455631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expressive levels of MUC1 and MUC5AC and their clinicopathologic significances in the benign and malignant lesions of gallbladder.
    Xiong L; Yang Z; Yang L; Liu J; Miao X
    J Surg Oncol; 2012 Jan; 105(1):97-103. PubMed ID: 21815153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of ephrin-A7 and metadherin and its clinicopathological significances in the benign and malignant lesions of gallbladder].
    Liu DC; Yang ZL
    Zhonghua Wai Ke Za Zhi; 2011 Mar; 49(3):250-5. PubMed ID: 21609571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine (C-X-C motif) ligand 12 is associated with gallbladder carcinoma progression and is a novel independent poor prognostic factor.
    Lee HJ; Lee K; Lee DG; Bae KH; Kim JS; Liang ZL; Huang SM; Suk Oh Y; Kim HY; Jo DY; Min JK; Kim JM; Lee HJ
    Clin Cancer Res; 2012 Jun; 18(12):3270-80. PubMed ID: 22553346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xanthogranulomatous cholecystitis: a clinicopathological study of its association with gallbladder carcinoma.
    Zhuang PY; Zhu MJ; Wang JD; Zhou XP; Quan ZW; Shen J
    J Dig Dis; 2013 Jan; 14(1):45-50. PubMed ID: 23134201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucin 5B, carbonic anhydrase 9 and claudin 18 are potential theranostic markers of gallbladder carcinoma.
    Espinoza JA; Riquelme I; Sagredo EA; Rosa L; García P; Bizama C; Apud-Bell M; Leal P; Weber H; Benavente F; Vargas S; Romero D; Kalergis AM; Roa JC
    Histopathology; 2019 Mar; 74(4):597-607. PubMed ID: 30565710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xanthogranulomatous cholecystitis: a premalignant condition?
    Ghosh M; Sakhuja P; Agarwal AK
    Hepatobiliary Pancreat Dis Int; 2011 Apr; 10(2):179-84. PubMed ID: 21459725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.